Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 359-366

  Romero, Diana ^a   Terzic, Aleksandra ^a   Conley, Barbara A ^a   Craft, Clarissa S ^b   Jovanovic, Borko ^c   Bergan, Raymond C ^c   Vary, Calvin P H ^c  

^a Maine Medical Center Research Institute   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; GROWTH FACTOR RECEPTOR; PROTEIN ALK2; SMAD PROTEIN; THREONINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1 PROTEIN, HUMAN; BMP7 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; HYBRID PROTEIN; LEUKOCYTE ANTIGEN; OSTEOGENIC PROTEIN 1; PHOSPHOTHREONINE; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ADENOCARCINOMA; ANIMAL; CANCER INVASION; CELL MOTION; CHEMISTRY; DRUG EFFECT; FEMALE; GENE DELETION; GENETICS; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROSTATE TUMOR; PROTEIN PROCESSING; TRANSPLANTATION; TUMOR CELL LINE; XENOGRAFT;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; BONE MORPHOGENETIC PROTEIN 7; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PHOSPHORYLATION; PHOSPHOTHREONINE; PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS;

EID: 77950911663     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp217     Document Type: Article

References (37)

1. Ao, M. et al. (2006) Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res., 66, 8007-8016.
2. Craft, C.S. et al. (2007) Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway. Oncogene, 26, 7240-7250.
3. Massague, J. et al. (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell, 103, 295-309.
4. Derynck, R. et al. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 425, 577-584.
5. Bernabeu, C. et al. (2007) Novel biochemical pathways of endoglin in vascular cell physiology. J. Cell. Biochem., 102, 1375-1388.
6. Cheifetz, S. et al. (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem., 267, 19027-19030.
7. Barbara, N.P. et al. (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J. Biol. Chem., 274, 584-594.
8. Lastres, P. et al. (1996) Endoglin modulates cellular responses to TGF-beta 1. J. Cell Biol., 133, 1109-1121.
9. Bourdeau, A. et al. (2000) Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia. Trends Cardiovasc. Med., 10, 279-285.
10. Arthur, H.M. et al. (2000) Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol., 217, 42-53.
11. Li, D.Y. et al. (1999) Defective angiogenesis in mice lacking endoglin. Science, 284, 1534-1537.
12. Mancini, M.L. et al. (2009) Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis. Dev. Dyn. (epub ahead of print).
13. Mancini, M.L. et al. (2007) Endoglin is required for myogenic differentiation potential of neural crest stem cells. Dev. Biol., 308, 520-533.
14. Mercado-Pimentel, M.E. et al. (2007) Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev. Biol., 304, 420-432.
15. Koleva, R.I. et al. (2006) Endoglin structure and function: determinants of endoglin phosphorylation by transforming growth factor-beta receptors. J. Biol. Chem., 281, 25110-25123.
16. Lamouille, S. et al. (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood, 100, 4495-4501.
17. Meng, Q. et al. (2006) Identification of Tctex2beta a novel dynein light chain family member interacting with different TGF-beta receptors. J. Biol. Chem., 281, 37069-37080.
18. Lee, N.Y. et al. (2007) The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J. Biol. Chem., 282, 21507-21517.
19. Sanz-Rodriguez, F. et al. (2004) Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the lim family of proteins. J. Biol. Chem., 279, 32858-32868.
20. Conley, B.A. et al. (2004) Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J. Biol. Chem., 279, 27440-27449.
21. Muenzner, P. et al. (2005) CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J. Cell Biol., 170, 825-836.
22. Guerrero-Esteo, M. et al. (1999) Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. Eur. J. Cell Biol., 78, 614-623.
23. Bernabeu, C. et al. (2009) The emerging role of Tgf-beta superfamily coreceptors in cancer. Biochim. Biophys. Acta. (epub ahead of print).
24. Quintanilla, M. et al. (2003) Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. Oncogene, 22, 5976-5985.
25. Liu, Y. et al. (2002) Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene, 21, 8272-8281.
26. Craft, C.S. et al. (2008) Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells. Mol. Pharmacol., 73, 235-242.
27. Bergan, R. et al. (1996) Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1integrin. Clin. Exp. Metastasis, 14, 389-398.
28. Monteiro, R.M. et al. (2004) Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins. J. Cell Sci., 117, 4653-4663.
29. Piek, E. et al. (1999) Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1. Int. J. Cancer, 80, 756-763.
30. Huang, X. et al. (2005) Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res., 65, 3470-3478.
31. Bhowmick, N.A. et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science, 303, 848-851.
32. Tu, W.H. et al. (2003) The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia, 5, 267-277.
33. Kim, I.Y. et al. (2000) Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res., 60, 2840-2844.
34. Miyazaki, H. et al. (2004) BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene, 23, 9326-9335.
35. Yang, S. et al. (2005) Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res., 65, 5769-5777.
36. Perez-Gomez, E. et al. (2007) A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis. Cancer Res., 67, 10268-10277.
37. Oxmann, D. et al. (2008) Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype. Oncogene, 27, 3567-3575.